Clinical trial NCT03172637: Female Sexual Dysfunction in Renal Failure
Official title: Female Sexual Dysfunctions in Patients With Chronic Renal Failure
Study type: OBSERVATIONAL
Overall status: UNKNOWN
Conditions: Evaluations of Sexual Dysfunction of Female in Chronic Renal Failure
Lead sponsor: Assiut University
Sponsor class: OTHER
First posted: 2017-06-01
Enrollment: 100
Sex: FEMALE
Minimum age (years): 18
Maximum age (years): 45
Standard ages: ADULT
Observational model: CASE_CONTROL
Time perspective: CROSS_SECTIONAL
Sampling method: PROBABILITY_SAMPLE
Study population: The Female Sexual Function Index (FSFI) will be used to assess sexual function .This index includes 19 questions related to 6 parameters: sexual desire, sexual arousal, lubrication, orgasm, sexual satisfaction and dyspareunia. A face-to-face inter-view with each participant in which the FSFI questions will be verbally asked and answered and compare between them in effect of renal failure on sexuality.

Duration of chronic renal failure duration of dialysis ,number of sessions of dialysis per week,medical treatment, haemoglobin and creatinine level will be fullfilled.

Brief summary: A myriad of sexual problems affect men and women with chronic kidney disease (CKD), including decreased libido, erectile dysfunction, dysmenorrhea, and infertility. Menstrual abnormalities are common in CKD and many women are an-ovulatory .

Causes of sexual dysfunction in CKD include hormonal alterations along with vascular, neurologic, psychogenic, and other factors, such as medications, contribute to the development of sexual dysfunction . Sexual dysfunction in females is mainly due to hormonal factors and manifests mainly as menstrual irregularities, amenorrhea, lack of vaginal lubrication, and failure to conceive.

Detailed description: Hormonal changes in chronic kidney disease are seen in prolactine, gonadotropins, and gonadal hormones. In women with CKD, elevated levels of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) are common. These hormonal changes are detected in the early stages of kidney disease and progressively worsen as kidney disease progresse .

. Women with chronic renal failure commonly have elevated circulating prolactin levels. As in men with chronic renal failure, the hypersecretion of prolactin in this setting appears to be autonomous, as it is resistant to maneuvers designed to stimulate or inhibit its release.

It has been suggested that the elevated prolactin levels may impair hypothalamic-pituitary function and contribute to sexual dysfunction and galactorrhea in these patients. However, uremic women treated with bromocryptine rarely resume normal menses and continue to complain of galactorrhea (if present), despite normalization of the plasma prolactin concentration. Thus, factors other than hyperprolactinemia must be important in this setting .

Eligibility criteria: Inclusion Criteria:

* -Female patients with chronic renal failure (eGFR \<15 ml/min/1.7m2 ) on dialysis or not.
* Age from 18 to 45 years old.
* Married.
* Sexually active during the last 6 monthes.

Exclusion Criteria:

* Pregnant women.
* Other medical diseases ( diabetes mellitus ,cardiac disorders ,neurological disorders and other systematic diseases).
* Taking medications affect sexuality function e.g. antidepressant drugs.

Primary outcomes:
measure: effect of chronic renal failure in females on their sexuality function
timeFrame: two years
Secondary outcomes:
Other outcomes:
Locations:
Study officials:
References: